Itau Unibanco Holding S.A.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,000
Closed -$1.28K 448
2025
Q2
$1.28K Buy
+1,000
New +$79.8K ﹤0.01% 377
2025
Q1
Sell
-13,022
Closed -$1.17M 465
2024
Q4
$1.17M Buy
+13,022
New +$1.26M 0.04% 110
2020
Q1
Sell
-1,125
Closed -$107K 902
2019
Q4
$107K Buy
+1,125
New +$97.3K 0.01% 493

Other funds holding XBI

Itau Unibanco Holding S.A.'s XBI Position: Q3 2025 in Review

Itau Unibanco Holding S.A. sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 1,000 shares — an estimated $1.28K sold.

Itau Unibanco Holding S.A. first reported a position in XBI in Q4 2019 and held it in 3 quarters. The position peaked at $1.17M in Q4 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Itau Unibanco Holding S.A. reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,000 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.28K.
  • Itau Unibanco Holding S.A. first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 3 quarters.
  • Itau Unibanco Holding S.A.'s State Street SPDR S&P Biotech ETF position peaked at $1.17M in Q4 2024.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2025, filed 12 Nov 2025.